2011

• Psychological impact of colposcopy among women being followed-up for abnormal cervical smears: prevalence of worries, anxiety and depression at 4 months
  M O'Connor, C White, C Ruttle, C Martin, G Flannelly, G von Bunau, J O'Leary, L Pilkington, M Anglim, M Turner, N Farah, S Cleary, T Darcy, W Prendiville J Murphy, L Sharp on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)
• Attitudes of women and mothers towards HPV vaccination in Ireland: findings from a national population survey
  M O'Connor, Murphy J, Sharp L, Martin C, Pilkington L, Sheils O, O'Leary J, on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)
• Developing resources to support GPs and practice nurses in cervical screening and HPV: Preliminary results from the ATHENS trial
  McSherry L, Dombrowski S, Francis J, Murphy J, Martin C, O’Leary J, Sharp L for the ATHENS Group
• ATHENS (A Trial of HPV Education and Support): Phase 1- results of in-depth interviews
  McSherry L, Murphy J, Dombrowski S, Francis J, Martin C, O’Leary J, Sharp L for the ATHENS Group
• The psychological cost of screening women for cervical cancer in Ireland
  M O'Connor, J Murphy, L Sharp
• Post-colposcopy psychological effects at 4 months: A study of women in Ireland
  J Murphy, C White, C Ruttle, C Martin, G Flannelly, G von Bunau, J O'Leary, L Pilkington, M Anglim, M Turner, N Farah, S Cleary, T Darcy, W Prendiville, M O'Connor, L Sharp on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)
• How can uptake of cervical screening be increased? Comparisions of characteristics, attitudes, and beliefs of women who have had, or never had, a smear test
  M O'Connor, Murphy J, Sharp L, on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)
• Barriers to accessing information and factors that impact on women's HPV information needs: implications for cervical screening programmes
  O'Connor M, Costello L, Murphy JC, Hayes Jordan D, Murphy J, Bastick P, Farrar K, Martin M, Prendiville W, Sharp L, on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)
• Women's experience and views of HPV testing: a qualitative study of the impact of HPV testing on women
  M O'Connor, L Costello, J Murphy, W Prendiville, L Sharp on behalf of CERVIVA with the staff at the AMNCH colposcopy clinic
• Comparison of HPV DNA detection technologies; Hybrid capture II (Qiagen) and Cervista™ HPV HR (Hologic UK Ltd
  Keegan H , Pilkington L , O' Brien R, Jamieson J, Wilson RT, Carson J, Martin CM ,O'Leary JJ
• Biomarkers and HR-HPV results in high precision screening diagnosis
  Jeney C, Mózes J, Varga N, Benczik M, Kovács A, Kaltenecker B, Lukács A, Babarczi E, Koiss R, Keegan H, Pilkington L, Spillane C, Martin CM, O'Leary JJ
• Developing resources to support GPs and practice nurses in cervical screening and HPV: Preliminary results from the ATHENS study
  McSherry LA, S Dombrowski, J Francis, J Murphy, C Martin, J O’Leary, L Sharp for the ATHENS group
• Psychological after-effects of colposcopy: prevalence of worries, anxiety and depression at 4 months
  M O'Connor, C White, C Ruttle, C Martin, G Flannelly, G von Bunau, J O'Leary, L Pilkington, M Anglim, M Turner, N Farah, S Cleary, T Darcy, W Prendiville J Murphy, L Sharp on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)
• HPV E6/7 mRNA and HPV DNA testing in post colposcopic treatment surveillance of cervical intraepithelial neoplasia
  L. Pilkington, H. Keegan, C. White, C. Spillane, S. O'Toole, O. Sheils, S. Singh, S. Cleary, W. Prendiville, T. Darcy, M.J. Turner, G. Von Bunau, M. Anglim, J.J. O'Leary, C.M. Martin
• Women's views of HPV vaccination in Ireland: findings from a national population survey
  O'Connor M, Murphy J, Sharp L, Martin C, Pilkington L, Sheils O, O'Leary J, on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)
• Developing resources to support primary care health professionals in cervical screening and HPV: Preliminary results from ATHENS
  McSherry L, Dombrowski S, Francis J, Murphy J, Martin C, O'Leary J, Sharp L for the ATHENS Group
• Women's knowledge and views about HPV infection and vaccination: findings from a national population survey in Ireland
  O'Connor M, J Murphy, L Sharp, C Martin, L Pilkington, O Sheils, J O'Leary, on behalf of the Irish Cervical Screening Research Consortium (CERVIVA)
• Developing resources to support GPs and practice nurses in cervical screening and HPV: Preliminary results from semi-structured interviews in the ATHENS study
  McSherry L, Dombrowski S, Francis J, Murphy J, Martin C, O'Leary J, Sharp L for the ATHENS Group
• Utility of HPV DNA/mRNA testing and smoking as a risk factor in predicting high grade cervical disease in women presenting with low grade abnormal smears
  White C, Ruttle C, Pilkington L, McInerney J, Keegan H, O'Toole S, Spillane C , Sharp, L, O'Kelly R, Fitzpatrick M, Lenehan P, Flannelly G, O'Leary J, Martin CM
• Comparison of Hybrid Capture 2 (Qiagen), Full-Spectrum HPV (GenoID), GenoID Molecular Beacon real-time HPV Assay with genotyping by Linear Array (Roche) in an Irish colposcopy population
  Keegan H, Pilkington L, Mc Inerney J, Pal-Szenthe B, Benczik M, Kaltenecker B, Mózes J, Kovács A and Solt A, Bolger N, Jeney C, O'Leary JJ, Martin CM